| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Off,Svp-r&D | Chief Scientific Off,Svp-r&D | Sr Vp-research &Development +1 more
1 company
Menzaghi Frederique Ph.d. is a Chief Scientific Off,Svp-r&D at TVRD. Recent filings cover 0 purchases and 48 sales.
Our model assigns Menzaghi Frederique Ph.d. a strong insider score of 85/100, based on 7 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +64.8%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2023 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Off,Svp-r&D | Sell | 2,993 | $3.51 | $10,505.43 | -1.9% | -50.6% | -92.0% | |
| Apr 4, 2023 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Off,Svp-r&D | Sell | 2,733 | $4.91 | $13,419.03 | -1.7% | -38.8% | -80.9% | |
| Mar 3, 2023 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Off,Svp-r&D | Sell | 6,802 | $9.71 | $66,047.42 | -4.1% | -69.9% | -90.8% | |
| Dec 21, 2022 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Off,Svp-r&D | Sell | 3,506 | $11.27 | $39,512.62 | -2.1% | -51.4% | -94.7% | |
| Apr 1, 2022 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Off,Svp-r&D | Sell | 1,784 | $11.91 | $21,247.44 | -1.0% | -27.9% | -61.2% | |
| Feb 25, 2022 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Off,Svp-r&D | Sell | 2,114 | $10.29 | $21,753.06 | -1.2% | -23.4% | -4.1% | |
| Aug 30, 2021 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Off,Svp-r&D | Sell | 3,847 | $14.20 | $54,627.40 | -2.7% | -15.2% | -29.8% | |
| Mar 5, 2021 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Off,Svp-r&D | Sell | 3,358 | $17.98 | $60,376.84 | -2.7% | - | - | |
| Feb 25, 2021 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Off,Svp-r&D | Sell | 5,003 | $19.33 | $96,707.99 | -4.3% | - | - | |
| Dec 30, 2020 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Off,Svp-r&D | Sell | 2,812 | $15.30 | $43,023.60 | -2.5% | - | - |